Oncogenic pathway signatures in human cancers as a guide to targeted therapies

Area of Science:

• Oncology
• Molecular Biology
• Genomics

Background:

• Cancer development involves accumulating mutations that deregulate cell signaling pathways controlling growth and fate.
• Gene expression signatures from DNA microarrays have shown potential in defining cancer subtypes, recurrence, and therapy response.
• Gene expression profiles can be utilized for analyzing oncogenic pathways.

Purpose of the Study:

• To identify gene expression signatures reflecting the activation status of oncogenic pathways.
• To evaluate these signatures in human cancers for patterns of pathway deregulation and associations with disease outcomes.
• To explore the potential of these signatures in predicting sensitivity to targeted cancer therapies.

Main Methods:

• Utilized DNA microarray-based gene expression profiling.
• Developed and evaluated gene expression signatures for oncogenic pathway activation.
• Analyzed large collections of human cancer data.
• Clustered tumors based on pathway signatures.
• Assessed predictions in cancer cell lines.

Main Results:

• Identified gene expression signatures that accurately reflect oncogenic pathway activation status.
• Demonstrated that these signatures identify patterns of pathway deregulation in tumors, correlating with clinical outcomes.
• Showed that combining pathway signatures distinguishes specific cancers and tumor subtypes.
• Clustering tumors by pathway signatures revealed prognostic information for patient subsets.
• Predicted drug sensitivity in cancer cell lines based on pathway deregulation.

Conclusions:

• Gene expression signatures can identify and reflect oncogenic pathway deregulation in human cancers.
• These signatures are linked to cancer biology, disease outcomes, and prognosis.
• Pathway deregulation signatures can predict sensitivity to targeted therapeutics, guiding personalized treatment strategies.